62 related articles for article (PubMed ID: 8926755)
1. [Behavior of cytosolic tissue polypeptide specific antigen in infiltrating ductal carcinoma of the breast classified as a function of percentage of cells in S phase of the cell cycle].
Alvarez A; Martínez Rodríguez I; Núñez MI; Ruibal A
Med Clin (Barc); 1996 Jun; 107(3):116. PubMed ID: 8926755
[No Abstract] [Full Text] [Related]
2. Estrogen receptor immunohistochemistry cutoff value: standardization is needed.
Arslan C; Dizdar O; Altundag K
Hum Pathol; 2010 Jan; 41(1):150; author reply 150-1. PubMed ID: 19762068
[No Abstract] [Full Text] [Related]
3. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
[No Abstract] [Full Text] [Related]
4. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers.
Leal C; Henrique R; Monteiro P; Lopes C; Bento MJ; De Sousa CP; Lopes P; Olson S; Silva MD; Page DL
Hum Pathol; 2001 May; 32(5):487-93. PubMed ID: 11381366
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of HER-2/neu overexpression among Iranian women with breast cancer: true or false?
Saatee S; Afrakhteh M; Sadrolhefazi B
Breast J; 2006; 12(5):499-501. PubMed ID: 16958978
[No Abstract] [Full Text] [Related]
6. Ductal carcinoma in situ of the breast: correlation between histologic classifications and biologic markers.
Moreno A; Lloveras B; Figueras A; Escobedo A; Ramon JM; Sierra A; Fabra A
Mod Pathol; 1997 Nov; 10(11):1088-92. PubMed ID: 9388058
[TBL] [Abstract][Full Text] [Related]
7. [Hyaluronic acid concentrations in cell membranes are inversely proportional to histological grade and ploidy in infiltrating ductal carcinoma of the breast].
Ruibal A; Núñez M; Tejerina A
Rev Esp Med Nucl; 1998; 17(4):310-1. PubMed ID: 9721348
[No Abstract] [Full Text] [Related]
8. [Dna synthesis and expression of steroid receptors in cells of human breast carcinoma].
Simone G; Mangia A; Petroni S; Marzullo F; Paradiso A; Schittulli F
Pathologica; 1996 Apr; 88(2):111-6. PubMed ID: 8927445
[TBL] [Abstract][Full Text] [Related]
9. Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer.
Rudolph P; Alm P; Olsson H; Heidebrecht HJ; Fernö M; Baldetorp B; Parwaresch R
Hum Pathol; 2001 Mar; 32(3):311-9. PubMed ID: 11274641
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of fibroblast growth factor receptor 3 in human breast cancer: correlation with clinicopathological/molecular parameters and prognosis.
Kuroso K; Imai Y; Kobayashi M; Yanagimoto K; Suzuki T; Kojima M; Ueda Y
Pathobiology; 2010; 77(5):231-40. PubMed ID: 21116113
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and biological differences between tetraploid and hypertetraploid infiltrating ductal carcinomas of the breast. Preliminary study].
Ruibal A; del Río MC; Arias J; Schneider J; Tejerina A
Rev Esp Med Nucl; 2000 Jun; 19(3):247-8. PubMed ID: 11062091
[No Abstract] [Full Text] [Related]
12. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.
Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128
[TBL] [Abstract][Full Text] [Related]
13. [Infiltrating ductal carcinomas of the breast in women over 60 years of age. Association with higher cellular proliferation and lower PS2, cell surface and cytosolic hyaluronic acid concentrations].
Ruibal A; Arias J; Del Río MC; Resino C; Tejerina A
Rev Esp Med Nucl; 2001 Dec; 20(7):525-9. PubMed ID: 11709137
[TBL] [Abstract][Full Text] [Related]
14. [Biological features of breast cancer in patients under 35].
Damenia AO; Turkevich EA; Semiglazov VF; Kochetova IA; Gurbanov SS; Bit-Sava EM; Efimenko AV
Vopr Onkol; 2007; 53(6):674-6. PubMed ID: 18416136
[TBL] [Abstract][Full Text] [Related]
15. Mitotic counts provide additional prognostic information in grade II mammary carcinoma.
Lynch J; Pattekar R; Barnes DM; Hanby AM; Camplejohn RS; Ryder K; Gillett CE
J Pathol; 2002 Mar; 196(3):275-9. PubMed ID: 11857489
[TBL] [Abstract][Full Text] [Related]
16. The biological and prognostic significance of cell polarity and E-cadherin in grade I infiltrating ductal carcinoma of the breast.
Tan DS; Potts HW; Leong AC; Gillett CE; Skilton D; Harris WH; Liebmann RD; Hanby AM
J Pathol; 1999 Sep; 189(1):20-7. PubMed ID: 10451483
[TBL] [Abstract][Full Text] [Related]
17. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
[TBL] [Abstract][Full Text] [Related]
18. Biologic tumor markers, lymph node status, and decision about adjuvant chemotherapy for breast cancer.
Velanovich V
Am Surg; 1997 Apr; 63(4):330-3. PubMed ID: 9124752
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'.
Charafe-Jauffret E; Tarpin C; Bardou VJ; Bertucci F; Ginestier C; Braud AC; Puig B; Geneix J; Hassoun J; Birnbaum D; Jacquemier J; Viens P
J Pathol; 2004 Mar; 202(3):265-73. PubMed ID: 14991891
[TBL] [Abstract][Full Text] [Related]
20. Tumor growth fraction, expression of estrogen and progesterone receptors, p53, bcl-2 and cathepsin D activity in primary ductal invasive breast carcinoma and their axillary lymph node metastases.
Kristek J; Dmitrović B; Kurbel S; Sakić K; Krajinović Z; Blazicević V; Has B; Marjanović K
Coll Antropol; 2007 Dec; 31(4):1043-7. PubMed ID: 18217456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]